VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.

Journal Information

Full Title: Vaccine

Abbreviation: Vaccine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: VACCELERATE Consortium reports financial support was provided by European Union. VACCELERATE Consortium reports financial support was provided by Federal Ministry of Education and Research Bonn Office."

Evidence found in paper:

"4 Funding statement The VACCELERATE Site Network has received funding from the 10.13039/100001345European Union’s Horizon 2020 research and innovation programme (grant agreement No 101037867) and the 10.13039/100001345German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung [BMBF]) (grant agreement No BMBF01KX2040)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025